# Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments

> **NCT06777758** · PHASE4 · RECRUITING · sponsor: **Kaohsiung Veterans General Hospital.** · enrollment: 90 (estimated)

## Conditions studied

- Postoperative Complications
- Respiratory Depression
- Postoperative Nausea
- Vomiting
- Constipation

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT06777758
- **Lead sponsor:** Kaohsiung Veterans General Hospital.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-12
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06777758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06777758, "Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT06777758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*